Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase
Year: 2021
Type: conference-abstract
Source: European Respiratory Journal
Institutions: University of Cambridge, Wellcome/MRC Institute of Metabolic Science, NIHR Cambridge Biomedical Research Centre, Queen's University Belfast, Harefield Hospital, University of California, Los Angeles, Amsterdam University Medical Centers, University of Amsterdam, University of Nottingham, Nottingham Biomedical Research Centre, King's College London, Asthma UK, Observational & Pragmatic Research Institute, University of Michigan, Michigan Medicine, AstraZeneca (United Kingdom), AstraZeneca (United States), AstraZeneca (Spain)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3216012279
